Abstract
PCN86 - Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have